CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 15 No. 6
From Morbidity and Mortality Weekly Report 

Cigarette Smoking Among Adults—United States, 1998

June 1, 2001

One of the national health objectives for 2010 is to reduce the prevalence of cigarette smoking among adults to no more than 12% (objective 21.la). To assess progress toward meeting this objective, the Centers for Disease Control and Prevention (CDC) analyzed self-reported data from the 1998 National Health Interview Survey (NHIS) Sample Adult Core Questionnaire about cigarette smoking among adults in the United States. This report summarizes the findings of this analysis, which indicate that in 1998, 24.1% of adults were current smokers.

The 1998 NHIS Core Questionnaire was administered to a nationally representative sample (n = 32,440) of the US noninstitutionalized civilian population aged ³ 18 years; the overall response rate for the survey was 73.9%. Participants were asked, "Have you smoked at least 100 cigarettes in your entire life?" and "Do you now smoke cigarettes every day, some days, or not at all?" Current smokers were persons who reported both having smoked ³ 100 cigarettes during their lifetime and having smoked every day or some days at the time of the interview. Former smokers were those who had smoked ³ 100 cigarettes during their lifetime but did not currently smoke.

Attempts to quit were determined by asking current smokers, "During the past 12 months, have you stopped smoking for one day or longer because you were trying to stop smoking?" Data were adjusted for nonresponse and weighted to provide national estimates. Confidence intervals (CIs) were calculated using SUDAAN software for statistical analysis.

Prevalence Lowest Among Older and Educated Adults

In 1998, an estimated 47.2 million adults (24.1%), comprising 24.8 million men (26.4%) and 22.4 million women (22.0%), were current smokers (Table 1). Overall, 19.7% (95% CI = ± 0.6) of adults were "every-day smokers," and 4.2% (95% CI = ± 0.3) were "some-day smokers" (every-day smokers constituted 82.4% [95% CI = ± 1.01] of all smokers).

Prevalence of smoking was highest among persons aged 18 to 24 years (27.9%) and aged 25 to 44 years (27.5%), and lowest among persons aged ³ 65 years (10.9%). Prevalence of current smoking was highest among American Indians/Alaska Natives (40.0%), intermediate among non-Hispanic whites (25.0%) and non-Hispanic blacks (24.7%), and lowest among Hispanics (19.1%) and Asians/Pacific Islanders (13.7%).

Adults with ³ 16 years of education had the lowest smoking prevalence (11.3%), achieving the 2010 goal of reducing smoking rates to no more than 12%. Current smoking prevalence was highest among persons with 9 to 11 years of education (36.8%). Smoking prevalence was higher among persons living below the poverty level (1997 poverty thresholds from the Bureau of the Census, Economics, and Statistics Administration, US Department of Commerce, were used in these calculations.) (32.3%) than among those living at or above the poverty level (23.5%).

In 1998, an estimated 44.8 million adults (22.9% [95% CI = ± 0.6]) were former smokers, comprising 25.7 million men and 19.1 million women. Former smokers constituted 48.7% (95% CI = ± 1.0) of persons who had ever smoked ³ 100 cigarettes. Among current daily smokers in 1998, an estimated 15.2 million (39.2% [95% CI = ± 1.4]) had stopped smoking for at least 1 day during the preceding 12 months because they were trying to stop smoking.

Editorial Note From the CDC

The findings in this report suggest that the goal of reducing the prevalence of cigarette smoking among adults to ≤ 12% by 2010 will require aggressive public health efforts to implement comprehensive tobacco-control programs nationwide. The 1998 NHIS data also demonstrate substantial differences in smoking prevalence across populations.

In 1998, smoking prevalence among persons aged 18 to 24 years was as high as the prevalence among persons aged 25 to 44 years. Historically, smoking prevalence has been highest among persons aged 25 to 44 years and significantly lower among persons aged 18 to 24 years. Recent increases among persons aged 18 to 24 years may reflect the aging of the cohort of high-school students among whom current smoking rates were high during the 1990s. In addition, the increase may indicate increased initiation of smoking among young adults. The high prevalence of smoking among young adults indicates a need to focus tobacco-use prevention and treatment programs on both adolescents and young adults.

Smoking Prevalence Highest Among Native Americans

Smoking prevalence reported for racial/ethnic subgroups showed few changes from 1997 to 1998. Prevalence of current smoking among American Indians/Alaska Natives remained the highest in the nation. State and regional surveys indicate that the prevalence of smoking cessation among American Indians/Alaska Natives remains relatively low. Although many factors contribute to the high prevalence of smoking among American Indians/Alaska Natives, it is important to develop culturally appropriate prevention and control measures that distinguish between the use of manufactured tobacco products and the ceremonial use of tobacco.

National health objectives for 2010 that are focused on eliminating population disparities reinforce the need for greater surveillance and culturally responsive approaches to tobacco use across communities. In the United States, population disparities in smoking prevalence have been consistent from 1993 through 1998. For example, in 1993, an 8.3 (95% CI = ± 2.5) percentage-point difference in smoking prevalence existed between those at or above the poverty level and those below (23.8% and 32.1%, respectively). In 1998, the difference was 8.8 (95% CI = ± 1.9) percentage points (23.5% and 32.3%, respectively).

Similarly, differences in prevalence among various educational groups have not been reduced. In 1993, the difference between those with 9 to 11 years of education and those with ³ 16 years was 23.3 (95% CI= ± 3.0) percentage points (36.8% and 13.5%, respectively). In 1998, the difference was 25.5 (95% CI= ± 2.3) percentage points (36.8% and 11.3%, respectively). The relation between tobacco use and increased risk of failing or dropping out of high school demonstrates the necessity of reaching these students through school-based programs before they leave school.

Differences in prevalence among racial/ethnic subgroups have not been reduced. For example, in 1993, the difference between non-Hispanic whites and American lndians/Alaska Natives was 13.3 (95% CI = ± 8.7) percentage points (25.4% and 38.7%, respectively). In 1998, the difference between non-Hispanic whites and American Indians/Alaska Natives was 15.0 (95% CI= ± 9.8) percentage points (25.0% and 40.0%, respectively). The reduction of tobacco-related health disparities requires communities, states, and national organizations to take a multidisciplinary approach to tobacco prevention and control.

Limitations of Findings

The findings in this report are subject to at least two limitations. Because the questionnaire for the 1997 NHIS was redesigned completely, trend analysis or comparison with data from years before 1997 should be conducted with caution. Second, the sample size of certain subgroups (for example, American Indians/Alaska Natives) was small, possibly resulting in unstable estimates.

Although comprehensive programs are critical in reducing the burden of tobacco use, short-term decreases in tobacco-related morbidity and mortality can be achieved only by helping current smokers quit. To assist in this process, the US Department of Health and Human Services has released guidelines with specific evidence-based recommendations for tobacco-use treatment. Recommended interventions include individual, group, or telephone counseling that offers practical advice about and support for quitting; support from family and friends also improves success rates.

In addition, all smokers trying to quit should be encouraged to use a medication approved by the Food and Drug Administration—either nicotine(Drug information on nicotine) replacement therapy (gum, inhaler, nasal spray, or patch) or a nonnicotine pharmacologic aid (such as bupropion [Zyban]). To ensure that smokers interested in quitting receive appropriate treatment, health-care systems must make routine screening of tobacco use the standard of care and monitor (through quality assurance processes) the provision of appropriate interventions to smokers. Improving access to smoking cessation treatment by reducing cost barriers also increases the number of quitters.

A comprehensive approach to tobacco control will require treatment for nicotine dependence and efforts at national, state, and local levels to reduce youth smoking, promote smoke-free environments, support counter-marketing efforts, enforce laws and regulations, and eliminate disparities in tobacco use among population subgroups. Increased attention must be focused on groups that show no decline in smoking prevalence, including persons aged 18 to 24 years, adults with low education levels, and American Indians/Alaska Natives. Approaches with the widest scope (ie, economic, regulatory, and comprehensive) are likely to have the greatest long-term population impact.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





Reported by the Epidemiology Branch of the Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, CDC. Adapted from Morbidity and Mortality Weekly Report, 49(39):881-884, 2000.


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 48-Year-Old Woman With Irregular Vaginal Bleeding
Brian Morse, MD1 , June 10, 2013

A 48-year-old female presents with complaints of irregular vaginal bleeding and postcoital bleeding. Images from a PET/CT and pelvis MRI reveal characteristic findings. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Bladder Cancer Recurrence High, Better Follow-Up Care Needed
  • ASCO: Post-Surgery Surveillance Found Safe in Seminoma
  • Fertility Preservation in Women With Breast Cancer: Challenges and Opportunities
  • Addressing Fertility Concerns in Women Diagnosed With Breast Cancer: Will Serial Reserve Screening Help?
  • Postmenopausal Hormone Receptor–Positive Advanced Breast Cancer
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • ASCO: No Benefit From Avastin in Newly Diagnosed Glioblastoma
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy